Briviact®

Active substance

 Brivaracetam

Holder

 UCB Pharma SA

Status

Closed

Indication

 Adjunctive treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy 

Public documents

Approbation

Information for the patient

Informed consent

Last update

15/09/2020
Last updated on